-
Patent Agency Ranking
公开(公告)号：US20240371398A1
公开(公告)日：2024-11-07
申请号：US18610154
申请日：2024-03-19
Applicant: Feel Therapeutics Inc.
Inventor： Georgios Eleftheriou , Panagiotis Fatouros , Charalampos Tsirmpas
Abstract: A method includes, for each user in a population: audio recording the user reciting a story configured to elicit an emotion associated with a psychiatric condition; concurrently recording a set of biosignals of the user; generating a set of psychophysiological markers correlating instances of the emotion and the set of biosignals; assessing a clinical assessment for the condition in the user; correlating the set of psychophysiological markers and the clinical assessment; and compiling the correlations into a model configured to predict risk of condition onset in a user. The method also includes: accessing a series of biosignals of a first user; identifying a series of psychophysiological markers in the series of biosignals; based on the series of psychophysiological markers and the model, calculating a risk of onset of the condition in the first user; and, in response to the risk exceeding a threshold, serving the notification to the first user.
-
公开(公告)号：US11967339B2
公开(公告)日：2024-04-23
申请号：US17861158
申请日：2022-07-08
Applicant: Feel Therapeutics Inc.
Inventor： Georgios Eleftheriou , Panagiotis Fatouros , Charalampos Tsirmpas
CPC classification number: G10L25/63 , G06F11/327 , G06V40/20
Abstract: A method includes: prompting a user to recite a story associated with a first target emotion; recording the user reciting the story and recording a first timeseries of biosignal data via a set of sensors integrated into a wearable device worn by the user; accessing a first timeseries of emotion markers extracted from the voice recording; labeling the first timeseries of biosignal data according to the first timeseries of emotion markers; generating an emotion model linking biosignals to emotion markers for the user based on the first emotion-labeled timeseries of biosignal data; detecting a second instance of the first target emotion exhibited by the user based on a second timeseries of biosignal data and the emotion model; and notifying the user of the second instance of the first target emotion.
-
公开(公告)号：US20240062910A1
公开(公告)日：2024-02-22
申请号：US18235510
申请日：2023-08-18
Applicant: Feel Therapeutics Inc.
Inventor： Georgios Eleftheriou , Panagiotis Fatouros , Charalampos Tsirmpas
CPC classification number: G16H50/30 , G16H50/20 , G16H40/67 , G16H20/10 , G06F21/602 , A61B5/165 , A61B5/74 , A61B5/4803 , A61B5/4848 , A61B5/4842 , A61B5/6801 , G06F40/35
Abstract: A method includes, during a first time, for each user in a population: accessing a clinical assessment for depression in the user; accessing a set of biosignal data of the user; deriving correlations between the set of biosignal data and the clinical assessment for depression; and compiling the correlations into a depression model configured to predict risk of future depression diagnosis. The method further includes, during a second time: accessing a series of biosignal data collected by a device worn by a first user; accessing a target duration; calculating a risk of presentation of depression symptoms by the first user within the target duration based on the series of biosignal data; and in response to the risk exceeding a threshold, serving a notification to a care provider associated with the first user, the notification indicating the risk and including a prompt to investigate the first user for treatment.
-
4.发明公开公开(公告)号：US20230301586A1
公开(公告)日：2023-09-28
申请号：US18126100
申请日：2023-03-24
Applicant: Feel Therapeutics Inc.
Inventor： Georgios Eleftheriou , Panagiotis Fatouros , Charalampos Tsirmpas
IPC: A61B5/00 , G16H50/50 , A61B5/0205
CPC classification number: A61B5/4809 , G16H50/50 , A61B5/0205 , A61B5/4815
Abstract: One variation of a method includes: accessing a first timeseries of biosignal data collected by a wearable device worn by a user during a first time period; deriving a first insomnia profile, representative of a set of health indicators exhibited by the user during the first time period, based on the first timeseries of biosignal data; and selecting a treatment pathway for implementation by the user based on the first insomnia profile. The method further includes: accessing a second timeseries of biosignal data collected for the user by the wearable device during a second time period; deriving a second insomnia profile, representative of the set of health indicators exhibited by the user during the second time period, based on the second timeseries of biosignal data; and characterizing effectiveness of the treatment pathway based on a difference between the first insomnia profile and the second insomnia profile.
-
公开(公告)号：US20220343941A1
公开(公告)日：2022-10-27
申请号：US17861158
申请日：2022-07-08
Applicant: Feel Therapeutics Inc.
Inventor： Georgios Eleftheriou , Panagiotis Fatouros , Charalampos Tsirmpas
Abstract: A method includes: prompting a user to recite a story associated with a first target emotion; recording the user reciting the story and recording a first timeseries of biosignal data via a set of sensors integrated into a wearable device worn by the user; accessing a first timeseries of emotion markers extracted from the voice recording; labeling the first timeseries of biosignal data according to the first timeseries of emotion markers; generating an emotion model linking biosignals to emotion markers for the user based on the first emotion-labeled timeseries of biosignal data; detecting a second instance of the first target emotion exhibited by the user based on a second timeseries of biosignal data and the emotion model; and notifying the user of the second instance of the first target emotion.
-
-
-
-
Search Results
5
records
(took 0.018 seconds)
